Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health
We are pleased to share the announcement of the results of the clinical trial comparing heat stable carbetocin and oxytocin in prevention of postpartum haemorrhage.
Concept Foundation has contributed to the 2018 Maternal Health Campaign. Learn more about the impact of poor quality medicines from key thought leaders.
Two publications were released recently that provide significant new evidence on uterotonics used for prevention and treatment of postpartum haemorrhage.
Concept Foundation is pleased to announce that over the coming year it will be working to address maternal health supply gaps in Ethiopia, with a new grant from the RHSC Innovation Fund.
A third mifepristone product, manufactured by Acme Formulation in India, has received a positive score for procurement by the Expert Review Panel (ERP).
Fiona Theunissen, MBA and Dr Hans Vemer, CEO of Concept Foundation and former obstetrician, discuss why quality, which is by no means a given, is such an important consideration when purchasing maternal health medicines such as uterotonics.
Earlier this month, Concept Foundation, in collaboration with the World Health Organization (WHO), hosted a workshop on the Optimal Procurement of Affordable and Quality-Assured Life-Saving Commodities in Kampala, Uganda. The workshop went extremely well, and Concept Foundation would like to thank all of the participants for their engagement and commitment to ensuring the access and availability of these essential maternal health medicines to women around the world.